North America And Europe Artificial Pancreas Market- Regional Analysis
Among region, North America is estimated to hold a dominant position in the North America and Europe artificial pancreas market over the forecast period. North America holds 67.4% of the market share. This is due to the increasing focus by key market players on helping people with Type 1 diabetes to live. For instance, in July 2020, & DreaMed Diabetes, Ltd., announced the use of its Artificial Pancreas algorithm in Medtronic's new CE Marked MiniMed 780G Advanced Hybrid Closed Loop system.
Geographies covered:
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients